| Fri, 19 Oct 2018 14:28:28: | AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring
|
| Fri, 19 Oct 2018 14:14:11: | NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartis
|
| Fri, 19 Oct 2018 14:06:22: | Panel backing for key Shire drug beefs up Takeda's case for its $62B buyout
|
| Fri, 19 Oct 2018 13:15:41: | After Philippines safety scandal, Sanofi's Dengvaxia set for European approval
|
| Fri, 19 Oct 2018 08:28:03: | FiercePharmaAsia—China’s $1.3B vaccine fine; Lantus biosim retreat; Taiho’s VC fund
|
| Fri, 19 Oct 2018 07:13:21: | ESMO 2018 spotlights Merck’s Keytruda, Pfizer's Ibrance, AstraZeneca’s Lynparza and more
|
| Thu, 18 Oct 2018 22:28:31: | Clovis bolsters Rubraca's PARP-leading prostate cancer bid with big-time response data
|
| Thu, 18 Oct 2018 15:29:35: | Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
|
| Thu, 18 Oct 2018 14:57:34: | Insys drove ‘explosive' opioid painkiller sales by ‘owning’ physicians, Senate report reveals
|
| Thu, 18 Oct 2018 14:04:46: | AbbVie wards off another Humira biosim challenger with Fresenius Kabi settlement
|
| Thu, 18 Oct 2018 13:44:43: | GlaxoSmithKline’s job whacking touches U.S. consumer plant
|
| Wed, 17 Oct 2018 19:34:28: | Working through CEO swap, Pfizer plots job cuts in drive for 'simpler' structure
|
| Wed, 17 Oct 2018 15:05:59: | U.K. fights EpiPen shortage by extending injector expiry dates
|
| Wed, 17 Oct 2018 14:58:22: | Minnesota AG targets Sanofi, Eli Lilly and Novo Nordisk in latest insulin pricing attack
|
| Wed, 17 Oct 2018 13:53:40: | Can Pfizer's new breast cancer drug Talzenna really make a dent in the PARP field?
|
| Wed, 17 Oct 2018 13:38:08: | Mannkind's Afrezza Facebook page gets slapped by FDA's promo police
|
| Wed, 17 Oct 2018 13:27:10: | FDA spanks South Korea's Hanlim Pharm with warning letter
|
| Wed, 17 Oct 2018 13:13:53: | Amgen, Lilly migraine drugs nab Express Scripts backing, but Teva's shut out
|
| Tue, 16 Oct 2018 20:18:10: | FCB Health launches next-generation big data agency to better tell pharma brand stories
|
| Tue, 16 Oct 2018 18:35:15: | Officials deny shortage of Seqirus' Fluad in the U.K. as season nears
|
| Tue, 16 Oct 2018 15:15:44: | Azar deals woe to DTC—and a slap to Big Pharma—with vow to force prices into drug ads
|
| Tue, 16 Oct 2018 14:56:50: | Johnson & Johnson would be just fine without Zytiga, executives insist as patent decision looms
|
| Tue, 16 Oct 2018 14:41:05: | EU expands look at Zhejiang Huahai as impurities show up in other 'sartans'
|
| Tue, 16 Oct 2018 13:38:35: | Sanofi, Regeneron score positive Dupixent data in sinusitis as they await key FDA asthma verdict
|
| Mon, 15 Oct 2018 19:11:17: | Flu shot giant Sanofi teams with American Lung Association on get-vaccinated message to U.S. seniors
|
